| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 1.23 MB | Adobe PDF |
Orientador(es)
Resumo(s)
Nowadays, organic salts and ionic liquids (OSILs) containing active pharmaceutical ingredients (APIs) are being explored as drug delivery systems in modern therapies (OSILs-API). In that sense, this work is focused on the development of novel OSILs-API based on amphotericin B through an innovative procedure and the evaluation of the respective biological activity against Leishmania infantum. Several ammonium, methylimidazolium, pyridinium and phosphonium organic cations combined with amphotericin B as anion were synthesized in moderate to high yields and high purities by the water-reduced buffer neutralization method. All prepared compounds were characterized to confirm the desired chemical structure and the specific optical rotation ([α]D25) was also determined. The biological assays performed on L. infantum promastigotes showed increased activity against this parasitic disease when compared with the starting chloride forms and amphotericin B alone, highlighting [P6,6,6,14][AmB] as the most promising formulation. Possible synergism in the antiprotozoal activity was also evaluated for [P6,6,6,14][AmB], since it was proven to be the compound with the highest toxicity. This work reported a simple synthetic method, which can be applied to prepare other organic salts based on molecules containing fragile chemical groups, demonstrating the potential of these OSILs-AmB as possible agents against leishmaniasis.
Descrição
Palavras-chave
Organic salts and ionic liquids Amphotericin B Active pharmaceutical ingredients Leishmania infantum Leishmaniasis
Contexto Educativo
Citação
Ferraz, R., Santarém, N., Santos, A. F. M., Jacinto, M. L., Cordeiro-da-Silva, A., Prudêncio, C., Noronha, J. P., Branco, L. C., & Petrovski, Ž. (2022). Synthesis and Biological Evaluation of Amphotericin B Formulations Based on Organic Salts and Ionic Liquids against Leishmania infantum. Antibiotics, 11(12), 1841. https://doi.org/10.3390/antibiotics11121841
Editora
MDPI